1-3 of 3
Sylvie Fasola
Close
Sort by
Journal Articles

Improved Prognosis of Children and Adolescents with Acute Lymphoblastic Leukemia (ALL) and Very-High Minimal Residual Disease (MRD) and the End of Induction therapy (EOI)? Preliminary Results of the FRALLE 2000 Protocol

Jean-Michel Cayuela, Kheira Beldjord, Sylvie Fasola, Marie-Françoise Auclerc, MD, Benoît Brethon, Anne Auvrignon, Francoise Mechinaud, Virginie Gandemer, MD, Geneviève Margueritte, Pascale Blouin, Nathalie Grardel, Hélène Cavé, Elizabeth Macintyre, Leverger Leverger, MD, PhD, Andre Baruchel, MD
Journal: Blood
Blood (2008) 112 (11): 2541.
https://doi.org/10.1182/blood.V112.11.2541.2541
Published: 2008
Journal Articles

WT1 Overexpression after Induction Therapy in Children AML Is Associated with Higher Risk of Relapse.

Annick Blaise, Hugues Leroy, Anne Auvrignon, Paola Ballerini, Helene Lapillonne, Christine Perot, Francoise Mazingue, Sylvie Fasola, Cyril Flamant, Luc Douay, Guy Leverger, Claude Preudhomme, Judith Landman-Parker
Journal: Blood
Blood (2004) 104 (11): 2998.
https://doi.org/10.1182/blood.V104.11.2998.2998
Published: 2004
Journal Articles

Impact of HOX11L2 and TAL1/SCL Expression in T-Cell Acute Lymphoblastic Leukaemia (T-ALL): Results of the FRALLE 93 Protocol.

Paola Ballerini, Jean-michel Cayuela, Vahid Asnafi, Sylvie Fasola, Marie-francoise Auclerc, Yves Perel, Odile Lejars5, Marianne Debre6, Gerard Michel7, Virginie Gandemer8, Brigitte Pautard9, Thierry Leblanc, Elizabeth Macintyre, Guy Leverger, Andre Baruchel, Judith Landman-Parker
Journal: Blood
Blood (2004) 104 (11): 2047.
https://doi.org/10.1182/blood.V104.11.2047.2047
Published: 2004